Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Interest & Investment Income: 2020-2023

Historic Interest & Investment Income for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to $754,144.

  • Immuneering's Interest & Investment Income rose 46.10% to $754,144 in Q4 2023 from the same period last year, while for Dec 2023 it was $3.6 million, marking a year-over-year increase of 255.56%. This contributed to the annual value of $3.6 million for FY2023, which is 255.56% up from last year.
  • As of Q4 2023, Immuneering's Interest & Investment Income stood at $754,144, which was down 11.85% from $855,532 recorded in Q3 2023.
  • Immuneering's Interest & Investment Income's 5-year high stood at $1.2 million during Q2 2023, with a 5-year trough of $518 in Q4 2020.
  • Over the past 3 years, Immuneering's median Interest & Investment Income value was $182,935 (recorded in 2021), while the average stood at $399,280.
  • Within the past 5 years, the most significant YoY rise in Immuneering's Interest & Investment Income was 27,483.98% (2021), while the steepest drop was 91.54% (2021).
  • Over the past 4 years, Immuneering's Interest & Investment Income (Quarterly) stood at $518 in 2020, then spiked by 27,483.98% to $142,885 in 2021, then surged by 261.25% to $516,168 in 2022, then skyrocketed by 46.10% to $754,144 in 2023.
  • Its Interest & Investment Income was $754,144 in Q4 2023, compared to $855,532 in Q3 2023 and $1.2 million in Q2 2023.